Articles

Big pharma is investing in AI drug discovery through major partnerships with biotech and technology companies, aiming to find new drug targets and develop medicines faster.
Read More...

The success of GLP-1 medicines has changed the way healthcare professionals view obesity and metabolic diseases. Over the past few years, drugs such as semaglutide and tirzepatide have…
Read More...

The pharmaceutical industry is entering a new chapter as artificial intelligence (AI) begins to play a larger role in drug discovery and development. What once seemed like a futuristic…
Read More...

E&L examination is continuously growing in importance and given the current scrutiny paid by governing bodies including the FDA and MHRA, understanding the best practice and…
Read More...

Now in its 17th year, E&L Europe is set to take place on 6-7 November in Amsterdam and once again will feature leading industry experts covering the most pertinent topics impacting…
Read More...

An organization’s good “x-variable” practice (GxP) system is only as reliable as its validated state. Once a system is identified as a GxP system, the validation work has only just…
Read More...

SINOVAC Biotech Ltd. announced that it received the World Health Organization (WHO) prequalification for its Poliomyelitis Vaccine (Vero Cell, Inactivated Sabin strains) ("sIPV") on…
Read More...

CanSino Biologics Inc. announced that the National Medical Products Administration of China granted approval for the clinical trial application of its COVID-19 mRNA vaccine in China.…
Read More...

MaaT Pharma, a French clinical-stage biotech (Phase 3) and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival outcomes for patients…
Read More...

A recent report by the International Pharmaceutical Congress Advisory Association (IPCAA) and Ashfield Meetings & Events found an interesting conclusion: 92% of Health Care…
Read More...

We live in an era of increasing digital involvement. Audiences are inundated with more messages than ever before, and the competition for engagement is fierce. So how do you reach…
Read More...

When it comes to proving the value of a new medicine, pharma has to strike the right balance This article was written by eyeforpharma There are perhaps few buzzwords bandied…
Read More...

Value has become a buzzword, but its importance cannot be overstated. How do we ensure its survival? The beauty of language lies in the fact that it is personal. The meaning of…
Read More...

Bridging the gap between innovation and access is Percival Barretto-Ko's top priority The way he tells it, Percival Barretto-Ko owes a lot to the profession of teaching. The…
Read More...

One in 10 people in America is fighting a rare disease, or a disorder that affects fewer than 200,000 Americans. Although there are more than 7,000 rare diseases that collectively…
Read More...

When compared to medical therapies, a bariatric surgeon and an endocrinologist specializing in diabetes observed that the effectiveness of medical versus surgical intervention proved to…
Read More...

Tango Therapeutics which is a biotechnology company creating novel, targeted medicines for specific cancer subtypes claimed the addition of three experienced leaders with deep…
Read More...

Sweetch which is a mobile-health app that helps prevent and enhance outcomes in diabetes by encouraging long-term behavioral change declared thee outcomes of its clinical trial…
Read More...

According to the newly published research in Molecular and Cellular Proteomics describes a biomarker panel based on patient IgM antibodies that can certainly distinguish between Zika…
Read More...

FDA Commissioner, Scott Gottlieb affirmed that FDA vows to commit itself to addressing women's health issues by speaking directly to patients and their families about significant health…
Read More...